MedPath

Fertility Study of Women With Chronic Inflammatory Rheumatism

Conditions
Arthritis, Rheumatoid
Chronic Juvenile Arthritis
Ankylosing Spondylitis
Arthritis, Psoriatic
Interventions
Other: Questionnaire about fertility
Registration Number
NCT03452735
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Etiopathogenesis of Chronic inflammatory rheumatisms (CIR) includes genetic, autoimmune and environmental factors. Their impact on the quality of life is important, leading to a sometimes severe disability. Thus they are likely to affect female fertility through several mechanisms, including autoimmune since the association between immunity and fertility has already been demonstrated in other autoimmune diseases.

This study wants to evaluate and compare the birth rate between CIR and control group.

Detailed Description

Data collection will be carried out using a questionnaire submitted to women in charge of the rheumatology department of the University Hospital of Toulouse and having agreed to participate:

* women with Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis or Chronic juvenile arthritis for the chronic inflammatory rheumatism group

* women with a mechanical rheumatic pathology for the control group

The primary endpoint was birth rate after spontaneous or induced pregnancy in patients who attempted to procreate, in the CIR group and in the control group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
2900
Inclusion Criteria
  • Patient with Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Chronic juvenile arthritis, Chronic Inflammatory Rheumatism
  • Patient diagnosed before the age of 40
  • Patient having given her no opposition to her participation in research
  • For the control group: patient not suffering from chronic inflammatory rheumatism, having consulted in Rheumatology for a mechanical pathology
Exclusion Criteria
  • Patient> 40 years old at the time of diagnosis
  • Patient with insufficient medical data (treatments)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control GroupQuestionnaire about fertilityPatient between the ages of 18 and 50 years, not diagnosed with Chronic inflammatory rheumatism, having consulted in Rheumatology for a mechanical pathology, presenting no chronic pathology, having no chemo or radiotherapy or immunosuppressive therapy, or pelvic surgery before age 40 years who will answer to a questionnaire about fertility
patients diagnosed before age 40Questionnaire about fertilityPatient between 18 and 50 years-old with Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Chronic juvenile arthritis, Chronic Inflammatory Rheumatism who will answer to a questionnaire about fertility
Primary Outcome Measures
NameTimeMethod
Birth rate after spontaneous or induced pregnancyOne day

Birth rate after spontaneous or induced pregnancy in women who have tried to procreate in the chronic inflammatory rheumatism group and in the control group.

Secondary Outcome Measures
NameTimeMethod
Birth rate according to the treatments usedOne day

Birth rate in the CIR group according to the treatments used

Design timeOne day

Design time in the CIR group and in the control group

Rates of ectopic pregnancy, early or late spontaneous miscarriageone day

Rates of ectopic pregnancy, early or late spontaneous miscarriage, early or late pregnancy, children born dead, preterm birth in the CIR group and in the control group

Rates of desire for pregnancyOne day

Rates of desire for pregnancy and study of the reasons for this lack of desire for pregnancy in the CIR group and in the control group

Birth rate according to the activity of the diseaseOne day

Birth rate in the CIR group according to the activity of the disease

Rates of sexual dysfunctionOne day

Rates of sexual dysfunction in the CIR group and in the control group

Trial Locations

Locations (1)

University Hospital Toulouse

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath